Clinical characteristics of Guillain-Barré syndrome in a tropical country: A Brazilian experience

Acta Neurologica Scandinavica

Volumn 125, Issue 1, 2012, Pages 47-53

  Dourado, M E ^a,b   Felix R H ^a   da Silva, W K A ^b   Queiroz, J W ^a,b   Jeronimo, S M B ^a,b,c  

^a Universidade Federal do Rio Grande do Norte Centro de Ciencias da Saude Faculdade de Medicina   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^c Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais INCT DT MCT CNPq   (Brazil)

Author keywords

Critical care; Electromyography; Guillain Barr syndrome; Neuroimmunology; Neuropathy; Peripheral neuropathy

Indexed keywords

IMMUNOGLOBULIN;

ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ACUTE MOTOR AND SENSORY AXONAL NEUROPATHY; ACUTE MOTOR AXONAL NEUROPATHY; ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; AXONAL VARIANT; CHILD; CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; DEMYELINATING VARIANT; DIARRHEA; ELECTROPHYSIOLOGY; FEMALE; GENETIC VARIABILITY; GROUPS BY AGE; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; INFECTION; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; OPHTHALMOPLEGIA; PROGNOSIS; RURAL AREA; SCHOOL CHILD; TROPICS; URBAN AREA;

ADOLESCENT; ADULT; AGED; BRAZIL; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; MALE; MIDDLE AGED;

EID: 84155187377     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01503.x     Document Type: Article

References (38)

1. Van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 2008;7:939-50.
2. Yuki N. Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 2007;35:691-711.
3. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet 2005;366:1653-66.
4. Mckhann GM, Cornblath DR, Griffin JW et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-42.
5. Nagasawa K, Kuwabara S, Misawa S et al. Electrophysiological subtypes and prognosis of childhood Guillain-Barre syndrome in Japan. Muscle Nerve 2006;33:766-70.
6. Nachamkin I, Arzarte BP, Ung H et al. Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology 2007;69:1665-71.
7. Paradiso G, Tripoli J, Galicchio S, Fejerman N. Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barre syndrome: a reappraisal. Ann Neurol 1999;46:701-7.
8. Van KR, Rico R, Gerstenbluth I et al. Gastroenteritis-associated Guillain-Barre syndrome on the Caribbean island Curacao. Neurology 2001;56:1467-72.
9. Kushnir M, Klein C, Pollak L, Rabey JM. Evolving pattern of Guillain-Barre syndrome in a community hospital in Israel. Acta Neurol Scand 2008;117:347-50.
10. Andrade IG, Queiroz JW, Cabral AP, Lieberman JA, Jeronimo SM. Improved sanitation and income are associated with decreased rates of hospitalization for diarrhoea in Brazilian infants. Trans R Soc Trop Med Hyg 2009;103:506-11.
11. Soares CN, Cabral-Castro M, Oliveira C et al. Oligosymptomatic dengue infection: a potential cause of Guillain-Barre syndrome. Arq Neuropsiquiatr 2008;66:234-7.
12. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27(Suppl):S21-4.
13. Meulstee J, Van Der Meche FG. Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. J Neurol Neurosurg Psychiatry 1995;59:482-6.
14. Mcgrogan A, Madle GC, Seaman HE, De Vries CS. The epidemiology of Guillain-Barre syndrome worldwide. A systematic literature review. Neuroepidemiology 2009;32:150-63.
15. Rocha MS, Brucki SM, Carvalho AA, Lima UW. Epidemiologic features of Guillain-Barre syndrome in Sao Paulo, Brazil. Arq Neuropsiquiatr 2004;62:33-7.
16. Franca MC Jr, Deus-Silva L, De Castro R et al. Guillain-Barre syndrome in the elderly: clinical, electrophysiological, therapeutic and outcome features. Arq Neuropsiquiatr 2005;63:772-5.
17. Dias-Tosta E, Kuckelhaus CS. Guillain-Barre syndrome in a population less than 15years old in Brazil. Arq Neuropsiquiatr 2002;60(2-B):367-73.
18. Rees JH, Gregson NA, Hughes RA. Anti-ganglioside GM1 antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-16.
19. Visser LH, Van Der Meche FG, Van Doorn PA et al. Guillain-Barre syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barre Study Group. Brain 1995;118(Pt 4):841-7.
20. Griffin JW, Li CY, Ho TW et al. Guillain-Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995;118(Pt 3):577-95.
21. Ho TW, Willison HJ, Nachamkin I et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome. Ann Neurol 1999;45:168-73.
22. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104-6.
23. Funakoshi K, Kuwabara S, Odaka M, Hirata K, Yuki N. Clinical predictors of mechanical ventilation in Fisher/Guillain-Barre overlap syndrome. J Neurol Neurosurg Psychiatry 2009;80:60-4.
24. Hauck LJ, White C, Feasby TE, Zochodne DW, Svenson LW, Hill MD. Incidence of Guillain-Barre syndrome in Alberta, Canada: an administrative data study. J Neurol Neurosurg Psychiatry 2008;79:318-20.
25. Yuki N, Odaka M. Ganglioside mimicry as a cause of Guillain-Barre syndrome. Curr Opin Neurol 2005;18:557-61.
26. De AE, Hayden FG, Mcauliffe JF et al. Acute respiratory viral infections in ambulatory children of urban northeast Brazil. J Infect Dis 1991;164:252-8.
27. Dourado ME, Duarte RC, Ferreira LC et al. Anti-ganglioside antibodies and clinical outcome of patients with Guillain-Barre syndrome in northeast Brazil. Acta Neurol Scand 2003;108:102-8.
28. Hao Q, Saida T, Kuroki S et al. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barre syndrome with preceding Campylobacter jejuni and other identified infections. J Neuroimmunol 1998;81:116-26.
29. Ropper AH, Shahani BT. Pain in Guillain-Barre syndrome. Arch Neurol 1984;41:511-4.
30. Hao Q, Saida T, Yoshino H, Kuroki S, Nukina M, Saida K. Anti-GalNAc-GD1a antibody-associated Guillain-Barre syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance. Ann Neurol 1999;45:758-68.
31. Durand MC, Porcher R, Orlikowski D et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barre syndrome: a prospective study. Lancet Neurol 2006;5:1021-8.
32. Plasma Exchange / Sandoglobulin Guillain-Barre Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Lancet 1997;349:225-30.
33. Walgaard C, Lingsma HF, Ruts L et al. Prediction of respiratory insufficiency in Guillain-Barre syndrome. Ann Neurol 2010;67:781-7.
34. Lawn ND, Wijdicks EF. Tracheostomy in Guillain-Barre syndrome. Muscle Nerve 1999;22:1058-62.
35. Van Der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med 1992;326(17):1123-9.
36. Hui AC, Chow KM, Tang AS, Fu M, Kay R, Wong KS. Electrophysiological, clinical and epidemiological study of Guillain-Barre Syndrome in Hong Kong Chinese. J Clin Neurosci 2005;12:134-6.
37. Hiraga A, Kuwabara S, Ogawara K et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barre syndrome. Neurology 2005;64(5):856-60.
38. Uncini A, Manzoli C, Notturno F, Capasso M. Pitfalls in electrodiagnosis of Guillain-Barre syndrome subtypes. J Neurol Neurosurg Psychiatry 2010;81:1157-63.